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Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is a 
degenerative disease of cardiomyocytes resulting in fi bro-fatty 
replacement and atrophy.(1) Although it affects mainly the right ventricle, 
the left ventricle may be involved. It may lead to arrhythmias, sudden 
cardiac death or heart failure. Affected individuals may be asymptomatic. 
The prevalence is unclear, but in the region of 1/1000, and it is familial 
in up to 50%.(2)
ARVC is primarily a desmosomal condition. Although there is no reason 
to believe that this desmosomal defect is regional and is known to 
affect both ventricles, it appears that the right ventricle takes the brunt 
pathophysiologically. The exact mechanism is still conjecture, but shear 
forces and stretch may play an important part.
Physical activity has many health-related, medical and cosmetic 
advantages. However, there is concern that its effects may not only be 
positive. Numerous reports of athletes dying suddenly, often of 
arrhythmias, gain much media coverage. It is possible that exercise may 
not only trigger potentially lethal arrhythmias in patients with an 
arrhythmia substrate but actually unveil subclinical cardiac conditions. 
Sport, possibly, is the factor that converts a defect of genotype to that 
of a specifi c abnormal potentially arrhythmogenic phenotype. 
The South African ARVC registry has been set up to study this condition. 
Data collected may help begin to answer questions regarding 
presentation and ventricular involvement. In the registry, baseline data 
have been collected, including physical and sporting activity. 
When the registry had recruited 75 patients with ARVC, with 61 of 
these being probands, it was analyzed for sport participation and 
exercise activity (Table 1). Of the 75 affected individuals, 42 (56%) 
were involved in regular sport participation, mostly aerobic exercise. 
The most common activity was road running, in 14 patients, followed 
by 6 involved with swimming and 6 with surfi ng. Nine patients were 
involved in a combination of sport activities, mostly running and 
swimming (Table 2). 
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COMMENTARY
  Sudden deaths have been reported in 
sportspersons and have been related to physical activity. 
It is possible that exercise may be a trigger of potentially 
lethal arrhythmias in susceptible individuals or may be the 
factor that converts a defect of genotype to an abnormal 
and arrhythmogenic phenotype. Patients with Arrhyth-
mogenic Right Ventricular Cardiomyopathy (ARVC) may 
be at higher risk of sports-related arrhythmias and 
sudden death.  In the South African ARVC registry, 56% 
of patients were involved in regular sport participation. 
Various potential mechanisms linking sport and exercise 
to arrhythmias in patients with ARVC may exist. 
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Number (n)  75
Gender ♂ = 51; ♀ = 24
Age (yrs) Average age: ♂ - 41; ♀ - 44 
 Range: 11 - 82 years
Sports Participation (% known) 42 (56%)
Symptoms Palpitations (+++++) 
  Near syncope (++++)
  Syncope (+++)
  Effort Intolerance (++)
  Chest Pain (+)
Medication Atenolol>Sotalol=Amiodarone
TABLE 1:  Demographic details of patients in the CASSA ARVC Registry (June 2008)
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It remains an interesting observation that amongst the ARVC patients, 
exercise participation is so common and at a level that appears to be 
higher than in the general population. 
The link between endurance sport and ARVC may be more than 
coincidental, as shown in animal studies, in which endurance training 
accelerates the development of right ventricular dysfunction and 
arrhythmia in heterozygous plakoglobin-defi cient mice, a defect of 
which is also known to occur in some ARVC patients.(3) It is our 
speculation that the right ventricle stretches from the increased venous 
return during exercise. Indeed, it has been suggested that the right 
ventricle might have a greater propensity to disease than the left 
ventricle because of its thinner wall and dilatory response to exercise.(4) 
In a person with a genetic predisposition to desmosomal failure, such 
stretch may result in disruption of the cardiac myocytes, resulting in 
their death and the macroscopic, ante or post mortem, observations 
seen in ARVC with structural fi bro-fatty changes and severely dilated, 
thinned-out right ventricles. 
The continued hemodynamic stress may further contribute to 
or exacerbate cardiac arrhythmias. There are data describing the 
association of exercise and right ventricular dysfunction. Post exercise 
RV, not LV, regional wall motion abnormalities and evidence of injury 
have been described in the past.(5,6) These may have been precipitated 
by high pulmonary artery (PAP) pressures: it has been noted that 
prolonged exercise at high altitudes may cause PAP to reach 65mmHg.(6) 
In some patients who develop pulmonary edema commonly seen at 
high altitude, high pulmonary artery pressures have been observed to 
occur during exercise at low altitude and to cause right ventricular and 
atrial dilatation.(7,8) It is possible that the patients with ARVC who are 
prone to arrhythmias may also develop high pulmonary pressures 
during exercise, resulting in ventricular stretch with its electropathophy-
siological consequences and right ventricular tachycardia. Another 
mechanism accounting for exercise-related arrhythmia may be due 
to the degenerative changes of ARVC, which may result in denervation 
of the myocardium and subsequent autonomic nerve terminal 
supersensitivity with abnormal response to catecholamines, resulting in 
pro-arrhythmic delayed afterdepolarizations during exercise.(9) 
Heidbuchel et al. recently looked at a cohort of 46 high endurance 
athletes and observed a high number of arrhythmic symptoms, sudden 
cardiac deaths, inducible ventricular tachycardia and structural 
cardiovascular abnormalities.(10) He also noted that most arrhythmic 
events occurred with mild or moderate activity and none during 
competitive participation. This is similar to our observation that most 
of the South African registry patients who experienced symptoms 
during exercise, were participating in non-competitive sporting activity. 
Most of Heidbuchel’s patients met criteria for ARVC, so they termed 
this an “acquired right ventricular dysplasia”.(10)
Patients with ARVC often receive ß-blockers for control. Most of 
the patients in the South African registry are on atenolol. In sport 
“addicted” ARVC patients, it is not uncommon to fi nd that they refuse 
to cease partaking in physical exercise activity. This together with the 
additional non-compliance of ß-blocker therapy, due to the unacceptable 
chronotropic side effects in sport, may double their risk of developing 
arrhythmias. 
At present the link between sport and ventricular involvement in a 
condition such as ARVC, although now shown in the experimental 
animal model, remains speculative in humans. International registries 
may help confi rm the association and genetic, hemodynamic and 
additional animal studies may establish the pathological link. The South 
African ARVC registry hopes to provide some of these answers.
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 Road  Swimming Surfi ng Soccer Rugby Squash Rowing Combination
 Running
 14 6 6 3 2 2 1 9
TABLE 2:  Type of sport and number of participants in the CASSA ARVC registry
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